Swiss Biotech Windward Raises $225 Million in US IPO, Placement
Windward Bio Group AG, raised about $225 million in a US initial public offering that priced at the midpoint of its marketed range, along with a private placement.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.